Roche NimbleGen, a provider of tissue-based cancer diagnostics, has launched a pre-capture multiplex target enrichment protocol.

The new pre-capture multiplex protocol enables multiple DNA samples to be barcoded and captured in a single SeqCap EZ Library reaction for exome or custom capture experiments.

Roche NimbleGen CEO Frank Pitzer said they are excited to provide researchers with pre-capture multiplex protocol that should allow researchers to increase the size of their studies, and thus, the statistical relevance.

Roche will soon launch Exome capture product which target 64Mb of coding exons and miRNAs, providing researchers with an efficient target enrichment product with the coverage of coding regions.